John Erbey

John is the founder of the Strataca Group and President of 3ive Labs. He has spent the past 20 years bringing innovative therapeutics and medical devices to the market. Prior to founding Strataca Systems, he held roles of increasing responsibility in marketing, portfolio planning, pricing, health economics and epidemiology at St Jude Medical, Bristol Myers Squibb, Schering Plough and SmithKline Beecham. He earned his doctorate in epidemiology from the University of Pittsburgh’s Graduate School of Public Health in 1998. His dissertation on the cardiovascular risk associated with insulin resistance in adults with type 1 diabetes (double diabetes) earned him induction into Delta Omega (the National Honor Society for Public Health). In addition, he has published 17 peer reviewed articles, and has delivered dozens of conference presentations and invited lectures.